BetaVia™ Novel Food Authorization Inspires Innovation and Ensures Peace of Mind

In a significant development for the nutraceutical industry, Kemin  has announced the attainment of Novel Food authorization from the European Commission for its groundbreaking product, BetaVia™ Pure. This authorization, coupled with a five-year exclusivity within the European Union, marks a milestone for Kemin and promises a new era of immune support and gut health for consumers across the continent.^1-2

BetaVia Pure represents the pinnacle of purity in beta-glucan supplements, boasting an impressive 95% beta 1,3 glucan content derived from Kemin's proprietary strain of Euglena gracilis algae. This innovative ingredient is meticulously manufactured through a patented process, ensuring unmatched quality and efficacy.³ Notably, BetaVia Pure stands out for its neutral odor, color, and low recommended dosage, making it exceptionally versatile for inclusion in a wide array of finished products.

Pedro Vieira, Vice President – Europe, Kemin Human Nutrition and Health, expressed his enthusiasm regarding this achievement, stating, "Receiving approval is a tremendous achievement that demonstrates the strength of the Novel Food dossier Kemin Human Nutrition and Health submitted to the European Commission." Vieira emphasized the significance of the European Union market for Kemin and underscored the company's commitment to delivering premium-quality nutritional solutions to consumers worldwide.

Notably, the Novel Food authorization encompasses a wide range of applications, including supplements tailored for different age groups, dietary replacements for weight management, and cereal bars catering to the general population. This versatility underscores BetaVia Pure's potential to revolutionize immune support and gut health across diverse demographics.

BetaVia's global regulatory status, extending beyond Europe to regions such as the U.S., Brazil, and Japan reinforces its credentials. Moreover, Kemin Human Nutrition and Health's commitment to natural sourcing ensures that BetaVia Pure is compliant with various dietary preferences and restrictions, including being GRAS, kosher, halal, vegetarian, gluten-free, allergen-free, and non-GMO.

For more information on formulating with BetaVia Pure for superior immune and gut support, visit kemin.com.

Resources

Subscribe to our Blog

These statements have not been evaluated by the US Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

The information on this webpage is a business-to-business information and not intended for the final consumer. Certain statements may not be applicable in all geographical regions. Product labeling and associated claims differs based upon government requirements and country or region specific information should also be considered when labeling or advertising to final consumers.

This web page and its associated brochures and other documents do not constitute or provide scientific or medical advice, diagnosis, or treatment and are distributed without warranty of any kind, either expressly or implied. This web page, its title or contents and associated brochures and other documents do not in any way make recommendations for health or marketing claims by the reader. Country and region specific regulations should be considered in this regard. Each claim or statement about the effectiveness of Kemin products and/or each claim or statement comparing the effectiveness of Kemin products to the effectiveness of other products is expressly limited to the United States, unless otherwise disclosed on the Kemin websites.

References:

1. https://www.efsa.europa.eu/en/efsajournal/pub/7995
2. https://eur-lex.europa.eu/eli/reg_impl/2024/1046/oj
3. Patents granted a patent on beta 1,3 glucans for modulating immune function (US Patent 10,912,794).  This new patent joins a previously issued patent, US 9574217, on the production of immune modulation using algae from a proprietary strain of Euglena gracilis ATCC PTA-123017